Title : Elusive sources of variability of dystrophin rescue by exon skipping.

Pub. Date : 2015

PMID : 26634117






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment with Phosphorodiamidate morpholino oligomers (PMO) lead to shorter de novo dystrophin protein in both animal models and DMD boys who otherwise lack dystrophin; however, restoration of dystrophin has been observed to be highly variable. DIAMIDOPHOSPHATE dystrophin Homo sapiens
2 Treatment with Phosphorodiamidate morpholino oligomers (PMO) lead to shorter de novo dystrophin protein in both animal models and DMD boys who otherwise lack dystrophin; however, restoration of dystrophin has been observed to be highly variable. DIAMIDOPHOSPHATE dystrophin Homo sapiens
3 Treatment with Phosphorodiamidate morpholino oligomers (PMO) lead to shorter de novo dystrophin protein in both animal models and DMD boys who otherwise lack dystrophin; however, restoration of dystrophin has been observed to be highly variable. DIAMIDOPHOSPHATE dystrophin Homo sapiens